Log In
Print
BCIQ
Print
Print this Print this
 

Stalevo, levodopa/carbidopa/entacapone

Also known as: Combination tablet of levodopa, carbidopa and entacapone

  Manage Alerts
Collapse Summary General Information
Company Orion Corp.
DescriptionLevodopa plus dopa decarboxylase inhibitor and catechol-O-methyl-transferase (COMT) inhibitor
Molecular Target Dopamine receptor
Mechanism of ActionDopamine receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat early-stage patients whose Parkinson's disease (PD) impairment requires the initiation of levodopa medication; Treat Parkinson's disease (PD)
Regulatory Designation

Partner

Novartis AG


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today